Market View: Bristol Myers $4.1 billion acquisition, Microstrategy, Intel, Adani Green, Apple, Vibecession ending, Chinese gaming firms share buybacks, Goldman’s 2023 lesson on China, Astrazeneca buys Cancer Drug Developer for $1.2 billion
Your Money with Michelle Martin27 Dec 2023

Market View: Bristol Myers $4.1 billion acquisition, Microstrategy, Intel, Adani Green, Apple, Vibecession ending, Chinese gaming firms share buybacks, Goldman’s 2023 lesson on China, Astrazeneca buys Cancer Drug Developer for $1.2 billion

Is the ‘vibecession’ really coming to an end? What’s the latest on Pharmaceutical acquisitions? And why are Chinese gaming firms unveiling share buybacks even after the latest regulatory move unnerved investors? Michelle Martin discusses with Ryan Huang.

See omnystudio.com/listener for privacy information.

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-borsens-finest
uppgang-och-fall
rss-svart-marknad
svd-tech-brief
avanzapodden
rss-dagen-med-di
dynastin
borsmorgon
lastbilspodden
fill-or-kill
24fragor
rss-den-nya-ekonomin
rss-kort-lang-analyspodden-fran-di
ekonomiekot-extra
rss-inga-dumma-fragor-om-pengar
bathina-en-podcast